A new study found that risk-based screening for breast cancer was as effective as standard annual mammography.

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...

University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based breast cancer screening and annual mammography. Rates of stage ≥IIB breast cancers met a ...

The fear of expectation and the unknown may often lead patients to refuse screenings or tests. It’s your job to try and help ...

A new generation of AI algorithms aim to go beyond detecting cancers to predicting risk for cardiovascular diseases.

A study of more than 45,000 women found that screening women according to their level of risk was as effective in detecting ...

A new study published in JAMA suggests that risk-based breast cancer screening could be a more effective approach than annual mammograms, but some experts fear it would be hard to do in practice.

New findings suggest blood tests still being assessed are showing promising results for early cancer screenings, especially ...

Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional ...

The blood test also had a sensitivity and specificity of 92.3% and 92.6% for participants who do not have breast cancer. The results were consistent for women with dense breast tissue and non-dense ...

The Office star Jenna Fischer revealed her battle with stage 1 triple-positive breast cancer, diagnosed in late 2023 after a routine mammogram. She underwent surgery, chemotherapy, and radiation, and ...